PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for June 28, 2009 Subscribe to this News Feed    
 

BioAllergenix Names Dr. Guy Annunziata as Chief Clinical Officer

BioAllergenix announces the appointment of Dr. Guy Annunziata to the position of Chief Clinical Officer. He comes to BioAllergenix after an impressive career in chiropractic care, practice management and academic instruction. Dr. Annunziata will help further BioAllergenix's mission to develop and offer safe and noninvasive therapies to alleviate suffering brought on by chronic health conditions. In the capacity as Chief Clinical Officer, his primary focus will be on training, education, management, and development of practice protocols in the use of neurological stress reduction therapy or NSRT. Established in 2007, BioAllergenix is an emerging industry leader in the holistic health care space, offering safe and effective alternatives to alleviate a myriad of health related conditions.

Boca Raton, FL (PRWEB) June 28, 2009 -- BioAllergenix is pleased to announce the appointment of Dr. Guy Annunziata to the position of Chief Clinical Officer. He comes to BioAllergenix after an impressive 24 year career in chiropractic care, practice management and academic instruction.    In the capacity as Chief Clinical Officer, his primary focus will be on training, education, management, and development of practice protocols in the use of neurological stress reduction therapy or NSRT. Established in 2007, BioAllergenix is an emerging industry leader in the holistic health care space, offering safe and effective alternatives to alleviate a myriad of health related conditions.

Dr. Annunziata graduated from Life College, School of Chiropractic and also received his Physiological Therapeutics Board Certification from the National College of Chiropractic. He has expertise in lower back case management and myofascial pain syndrome, subluxation, postural correction and functional rehabilitation. His practices in both Atlanta and South Carolina employed state-of-the-art diagnostics, including high frequency x-ray, NCV and DSEP Studies, MRI and CT Scans. Dr. Annunziata has also served as COO of the Rehab Clinics of America which was sold in 2008.

Dr. Annunziata is recognized as a premier educator in the chiropractic community through his company "Advanced Health Care Solutions" which offers continuing education nationally with courses on a variety of topics which include low back case management, myofascial pain syndrome with trigger point therapy, spinal decompression, whiplash case management, medical documentation, physical therapy and rehab of the spine.

Since September 2001, Annunziata has served as a post-graduate instructor at the University of Bridgeport and, most recently, at LIFE University. He has raised the bar in continuing education capabilities through the establishment of online courses.

"Dr. Annunziata's collective experience in practice and as an educator made him the perfect fit to expand our training programs to further educate our customer base and lead the work necessary to refine our practice protocols while overseeing our clinical research," says Adam Silbersweig, President of BioAllergenix.

"I decided to accept this position with BioAllergenix because I truly believe that NSRT (Neurological Stress Reduction Therapy) can change the entire model of health care as we know it," explains Annunziata. "BioAllergenix is committed to shifting the paradigm of health in this country from a condition-based Western approach to one that is not solely engrossed in pharmaceutical dependency. I am excited to be a part of this change that will help the lives of people suffering from so many debilitating conditions."

About BioAllergenix:

BioAllergenix was established in 2007 with the introduction of the BAX-3000, the only fully-automated, patented and FDA cleared LASER (Light and Sound Energy Relaxation) Therapy system. BioAllergenix's technology combines NSRT (Neurological Stress Reduction Therapy) and environmental substance exposure to reduce or eliminate inappropriate anatomic nervous system mediated responses. These responses are the triggers for symptoms associated with numerous chronic conditions such as allergies, asthma, migraines, chronic fatigue syndrome, irritable bowel syndrome, eczema and other skin conditions. BioAllergenix is committed to utilizing its technology to provide safe, fast, painless and noninvasive therapeutic alternatives rooted in neurological stress reduction therapy.

Contact:

Beth Bay, Director of Public Relations
BioAllergenix
1-877-229-3000
http://www.BAX3000webinar.com

# # #

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1aZXRhLUNyYXMtSW5zZS1NYWduLUNvdXAtWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Beth Bay
BioAllergenix
917-734-1523
Email us Here
ATTACHED FILES

Press Release Attachment

Press Release Attachment

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move